PRM Perimeter Group Inc.
Chemicals & Allied Products · NYSE · SEC CIK 1880319 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY30.7%
TTM net income YoY-28.8%
TTM EPS YoY-59.3%
Revenue 3-yr CAGR39.9%
Net income 3-yr CAGR4.4%
Margins
Gross margin54.5%
Operating margin14.5%
Net margin6.7%
FCF margin6.5%
EBITDA margin27.3%
Returns
ROE4.6%
ROA1.8%
ROIC (approx.)6.3%
Asset turnover0.28x
Leverage & solvency
Liabilities / assets60.8%
Debt / equity0.91x
Current ratio2.79x
Interest coverage1.63x
Cash quality & payout
Operating cash flow / net income1.66x
Accruals ratio-1.2%
Payout ratio—
Capex / revenue4.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $389.87M | $213.81M | $125.07M | $102.75M | $315.44M | $162.64M | $72.03M | $86.23M |
| Cost of revenue | $151.51M | $95.94M | $74.28M | $56.36M | $116.33M | $61.14M | $43.88M | $44.34M |
| Gross profit | $238.36M | $117.87M | $50.79M | $46.39M | $199.11M | $101.50M | $28.15M | $41.90M |
| SG&A expense | $30.74M | $26.99M | $23.06M | $21.83M | $23.48M | $15.97M | $16.30M | $21.01M |
| Operating income | $416.45M | -$203.02M | $72.49M | -$165.16M | -$87.35M | -$26.23M | $77.81M | $61.32M |
| Interest expense | $20.37M | $19.59M | $24.36M | $9.69M | $9.87M | $9.93M | $9.64M | $9.17M |
| Pretax income | $395.41M | -$221.44M | $49.85M | -$174.43M | -$97.15M | -$33.85M | $69.18M | $49.93M |
| Income tax | $90.94M | -$39.80M | -$23.09M | -$34.20M | -$6.49M | -$1.69M | $12.49M | -$94.24M |
| Net income | $304.47M | -$181.63M | $72.94M | -$140.23M | -$90.66M | -$32.16M | $56.69M | $144.17M |
| EBITDA | $446.58M | -$174.11M | $99.63M | -$144.74M | -$68.55M | -$8.30M | $94.70M | $77.82M |
| EPS (basic) | 1.86 | -1.11 | 0.47 | — | -0.62 | -0.22 | 0.38 | — |
| EPS (diluted) | 1.74 | -1.11 | 0.44 | — | -0.62 | -0.22 | 0.36 | — |
| Weighted avg. shares (diluted) | 174.96M | 163.41M | 165.07M | — | 146.80M | 147.06M | 156.73M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $115.91M | $82.78M | $91.62M | $325.93M | $340.65M | $140.66M | $200.05M | $198.46M |
| Short-term investments | — | — | — | — | — | — | — | $0 |
| Receivables | $176.57M | $158.09M | $87.54M | $64.36M | $106.69M | $121.42M | $44.65M | $56.05M |
| Inventory | $221.52M | $203.26M | $191.03M | $139.63M | $130.14M | $150.05M | $122.71M | $116.35M |
| Current assets | $548.11M | $496.39M | $398.17M | $563.97M | $584.15M | $420.08M | $385.44M | $394.02M |
| PP&E, net | $116.68M | $109.22M | $101.30M | $85.14M | $81.55M | $78.83M | $67.69M | $64.78M |
| Goodwill | $1.43B | $1.37B | $1.37B | $1.07B | $1.05B | $1.05B | $1.04B | $1.03B |
| Intangibles | $1.25B | $1.22B | $1.25B | $899.32M | $888.21M | $896.76M | $888.69M | $898.42M |
| Total assets | $3.40B | $3.24B | $3.16B | $2.65B | $2.65B | $2.49B | $2.41B | $2.42B |
| Current liabilities | $196.65M | $316.40M | $128.89M | $175.12M | $263.65M | $103.96M | $73.71M | $62.49M |
| Long-term debt | $1.21B | $1.21B | $1.21B | $669.12M | $668.78M | $668.44M | $668.10M | $667.77M |
| Total debt | $1.21B | $1.21B | $1.21B | $669.12M | $668.78M | $668.44M | $668.10M | $667.77M |
| Total liabilities | $2.07B | $2.22B | $1.96B | $1.52B | $1.53B | $1.31B | $1.19B | $1.26B |
| Shareholders' equity | $1.33B | $1.02B | $1.20B | $1.13B | $1.11B | $1.18B | $1.22B | $1.16B |
| Net debt | $1.09B | $1.13B | $1.12B | $343.19M | $328.13M | $527.78M | $468.05M | $469.32M |
| Shares outstanding | 163.69M | 163.69M | 163.13M | 149.44M | 147.92M | 145.91M | 148.78M | 147.82M |
| Cash flow statement | ||||||||
| Operating cash flow | $163.12M | -$654,000 | -$88.96M | $18.60M | $198.66M | -$2.85M | $23.75M | -$5.99M |
| Capital expenditure | $12.67M | $12.72M | $5.80M | $6.99M | $5.02M | $12.76M | $4.81M | $6.46M |
| Free cash flow | $150.44M | -$13.38M | -$94.76M | $11.61M | $193.63M | -$15.62M | $18.93M | -$12.45M |
| Investing cash flow | -$129.80M | -$12.72M | -$688.10M | -$46.99M | -$17.02M | -$27.99M | -$14.81M | -$39.25M |
| Financing cash flow | -$158,000 | $4.45M | $542.76M | $12.61M | $18.98M | -$32.17M | -$8.39M | $23.31M |
| Depreciation & amortization | $30.13M | $28.91M | $27.14M | $20.42M | $18.79M | $17.92M | $16.89M | $16.50M |
| Stock-based compensation | $4.38M | $2.89M | $2.60M | $5.22M | $6.52M | $2.24M | $2.67M | $4.80M |
| Share buybacks | $0 | $0 | $0 | $0 | $0 | $32.19M | $8.18M | $0 |
Free plan shows the latest 8 periods; Pro shows all 24 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.